Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease
Age and Ageing
- Angiotensin II receptor blockers
- Angiotensin-converting enzyme inhibitors
- Beta-blockers
- Alzheimer's disease
- Dementia
- Humans
The paper
Wang Y, Goudey B, Masters CL et al.
Age and Ageing · 4 Sep 2026


